Intriguingly, high B2M expression showed significantly better prognosis than low B2M expression in colon cancer (p = 0.0021, Fig 5D, right panel) similarly with CD8A, IFNG and TLR4 (Fig 4A and 4G). The gene discussed is CD8A; the disease is malignant colon neoplasm.